28 studies found for:    ICHTHYOSIS, X-LINKED
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  National Registry for Ichthyosis and Related Disorders
Conditions: Darier Disease;   Hailey-Hailey Disease;   Hyperkeratosis, Epidermolytic;   Ichthyosis;   Ichthyosis, Lamellar;   Ichthyosis, X-Linked;   Keratoderma
Intervention:
2 Recruiting STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)
Condition: Aortic Valve Stenosis
Intervention: Procedure: Transcatheter Aortic Valve Replacement
3 Recruiting Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)
Conditions: Sarcoma;   Leiomyosarcoma;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Fibrous;   Histiocytoma/Undifferentiated Pleomorphic Sarcoma
Intervention: Drug: Gemcitabine and Docetaxel in Combination with Pazopanib
4 Completed Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)
Conditions: Gastrointestinal Stromal Tumors;   Soft Tissue Sarcomas
Intervention: Drug: IPI-504
5 Recruiting Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Pazopanib
6 Unknown  Contribution of F18-FDG PET/CT to the Early Assessment of Pazopanib Therapy Efficacy in Advanced Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma (STS)
Intervention: Other: F18-FGD PET/CT
7 Recruiting STS/ACC TVT Registry Mitral Module
Condition: Mitral Valve Regurgitation
Intervention: Device: Leaflet Clip
8 Recruiting A Phase II Study of Anlotinib Hydrochloric Capsule in STS Patients
Condition: Cancer
Intervention: Drug: Anlotinib Hydrochloric Capsule
9 Completed Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Bendamustin
10 Active, not recruiting Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)
Condition: Sarcoma, Soft Tissue
Interventions: Drug: Adriamycin;   Drug: Trofosfamide
11 Active, not recruiting
Has Results
Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)
Condition: Soft Tissue Sarcoma
Interventions: Procedure: External Beam Radiation Therapy (RT);   Biological: Autologous Dendritic Cells
12 Completed Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)
Condition: Sarcoma, Soft Tissue
Interventions: Drug: Adriamycin;   Drug: Ifosfamide;   Drug: Etoposide;   Drug: Carboplatin
13 Recruiting Study in Patients With Advanced Soft Tissue Sarcoma (STS) After Failure of Anthracyclines and/or Ifosfamide
Condition: Soft Tissue Sarcoma
Intervention:
14 Unknown  Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)
Condition: Soft Tissue Sarcoma
Intervention: Drug: Vorinostat
15 Withdrawn A Pilot Study to Evaluate Topical Sodium Thiosulfate Therapy for Calcinosis Cutis
Condition: Calcinosis Cutis
Interventions: Drug: Sodium thiosulfate;   Drug: Placebo
16 Completed Selegiline for Smoking Cessation - 1
Condition: Nicotine Dependence
Intervention: Drug: Selegiline
17 Completed Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients
Conditions: Cognition Disorders;   HIV Infections
Intervention: Drug: Selegiline hydrochloride
18 Recruiting Trabectedin First Line Therapy In Unfit Sarcoma Study
Conditions: Metastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to Receive;   Standard Chemotherapy
Intervention: Drug: Trabectedin
19 Completed Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma
Intervention: Drug: soblidotin
20 Recruiting Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.
Condition: Locally Advanced or Metastatic Soft Tissue Sarcoma
Interventions: Drug: NGR-hTNF;   Drug: Doxorubicin

Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results
Indicates status has not been verified in more than two years